Preventing virus transmission among healthcare workers during the Middle East Respiratory Coronavirus Virus (MERS-CoV) outbreak
Citation: Rahman SAU. Transmission of Middle East respiratory syndrome coronavirus infections among healthcare personnel in the Middle East: A systematic review. Tropical Journal of Pharmaceutical Research 2018; 17(4): 731-9
What is this? Evidence on the use of personal protective equipment and infection control procedures to reduce transmission of the Middle East Respiratory Coronavirus Virus (MERS-CoV) to healthcare workers may help to inform similar strategies for COVID-19.
In this systematic review, the author searched for research on transmission of MERS-CoV Infection among healthcare workers in the Middle-East. They restricted their search to studies published in English. The manuscript was published in April 2018 but the date of the search is not reported. The author identified 4 cross-sectional studies, 3 retrospective studies, 1 prospective descriptive study, 1 case report, 1 primary case, 1 review study and 1 cohort study. Ten studies were from Saudi Arabia, 1 was from United Arab Emirates and 1 was from the Arabian Peninsula.
What works: The use of infection control procedures and protocols, which included ensuring that people with respiratory infection symptoms adhere to respiratory and hand hygiene, reduced the MERS-CoV infection rate among healthcare workers.
Rapid identification of high-risk patients with MERS-CoV and implementation of infection control precautions helped to protect healthcare workers from MERS-CoV.
What doesn’t work: Nothing noted.
What’s uncertain: Nothing noted.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.